Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes

Cellular Physiology and Biochemistry

Volumn 29, Issue 3-4, 2012, Pages 583-594

  Tie, Lu ^a   Yang, Hong Qin ^a,c   An, Yu ^a   Liu, Shao Qiang ^a,d   Han, Jing ^a   Xu, Yan ^a   Hu, Min ^a   Li, Wei Dong ^a   Chen, Alex F ^b   Lin, Zhi Bin ^a   Li, Xue Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Baoshan Chinese Traditional Medical College   (China)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Diabetes; Ganoderma lucidum polysaccharide (Gl PS); Manganese superoxide dismutase (MnSOD); Mitochondria; Nitrotyrosine; Oxidative stress; p66Shc

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; GANODERMA LUCIDUM POLYSACCHARIDE; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; POLYSACCHARIDE; PROTEIN P66; SUPEROXIDE; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG PENETRATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SKIN INJURY; WOUND HEALING;

GANODERMA LUCIDUM; MUS;

EID: 84859918779     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000338512     Document Type: Article

References (44)

1. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 1999;341:738-746. (Pubitemid 29407375)
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J: The global burden of diabetic foot disease. Lancet 2005;366:1719-1724. (Pubitemid 41587452)
3. Brem H, Tomic-Canic M: Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007;117:1219-1222. (Pubitemid 46718408)
4. Falanga V: Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-1743. (Pubitemid 41587454)
5. Giacco F, Brownlee M: Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070.
6. Fadini GP, Albiero M, Menegazzo L, Boscaro E, Pagnin E, Iori E, Cosma C, Lapolla A, Pengo V, Stendardo M, Agostini C, Pelicci PG, Giorgio M, Avogaro A: The redox enzyme p66shc contributes to diabetes and ischemiainduced delay in cutaneous wound healing. Diabetes 2010;59:2306-2314.
7. Huang C, Kim Y, Caramori ML, Moore JH, Rich SS, Mychaleckyj JC, Walker PC, Mauer M: Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes 2006;55:1826-1831. (Pubitemid 44324139)
8. Luo JD, Wang YY, Fu WL, Wu J, Chen AF: Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 2004;110:2484-2493. (Pubitemid 39407357)
9. Tie L, Li XJ, Wang X, Channon KM, Chen AF: Endothelium-specific gtp cyclohydrolase i overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes. Am J Physiol Endocrinol Metab 2009;296:E1423-1429.
10. Lin ZB: Cellular and molecular mechanisms of immuno-modulation by ganoderma lucidum. J Pharmacol Sci 2005;99:144-153.
11. Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS: Ganoderma ucidum: A potent pharmacological macrofungus. Curr Pharm Biotechnol 2009;10:717-742.
12. Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL: Effects of ganoderma lucidum polysaccharide on cyp2e1, cyp1a2 and cyp3a activities in bcg-immune hepatic injury in rats. Biol Pharm Bull 2007;30:1702-1706. (Pubitemid 47403249)
13. Zhou ZY, Tang YP, Xiang J, Wua P, Jin HM, Wang Z, Mori M, Cai DF: Neuroprotective effects of water-soluble ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol 2010;131:154-164.
14. Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, Ge ZH, Song YX, Xing EH, Li WD: Promoting effects of ganoderma lucidum polysaccharides on b16f10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol 2011;108:149-154.
15. He CY, Li WD, Guo SX, Lin SQ, Lin ZB: Effect of polysaccharides from ganoderma lucidum on streptozotocininduced diabetic nephropathy in mice. J Asian Nat Prod Res 2006;8:705-711.
16. Meng GL, Zhu HY, Yang SJ, Wu F, Zheng HH, Chen E, Xu JL: Attenuating effects of ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohyd Polym 2011;84:180-185.
17. Zhao HB, Lin SQ, Liu JH, Lin ZB: Polysaccharide extract isolated from ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/ reoxygenation injury. J Pharmacol Sci 2004;95:294-298.
18. Yang Q, Wang S, Xie Y, Sun J, Wang J: Hplc analysis of ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and bax, bcl-2 expression. Int J Biol Macromol 2010;46:167-172.
19. Cao LZ, Lin ZB: Regulation on maturation and function of dendritic cells by ganoderma lucidum polysaccharides. Immunol Lett 2002;83:163-169.
20. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC: Diabetic impairments in no-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and sdf-1 alpha. J Clin Invest 2007;117:1249-1259. (Pubitemid 46718413)
21. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M: The nonpsychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol 2007;556:75-83. (Pubitemid 46074009)
22. Marrotte EJ, Chen DD, Hakim JS, Chen AF: Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J Clin Invest 2010;120:4207-4219.
23. Tangpong J, Cole MP, Sultana R, Estus S, Vore M, St Clair W, Ratanachaiyavong S, St Clair DK, Butterfield DA: Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: Insight into the mechanism of chemobrain. J Neurochem 2007;100:191-201. (Pubitemid 46090774)
24. Bayir H, Kagan VE, Clark RS, Janesko-Feldman K, Rafikov R, Huang Z, Zhang X, Vagni V, Billiar TR, Kochanek PM: Neuronal nos-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 2007;101:168-181. (Pubitemid 46426473)
25. Francia P, Cosentino F, Schiavoni M, Huang Y, Perna E, Camici GG, Luscher TF, Volpe M: P66(shc) protein, oxidative stress, and cardiovascular complications of diabetes: The missing link. J Mol Med (Berl) 2009;87:885-891.
26. Zhang HN, He JH, Yuan L, Lin ZB: In vitro and in vivo protective effect of ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci 2003;73:2307-2319. (Pubitemid 36980827)
27. Li F, Zhang Y, Zhong Z: Antihyperglycemic effect of ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci 2011;12:6135-6145.
28. Zhang HN, Lin ZB: Prevention of lowdose of streptozotocin induced autoimmune diabetic mice with ganoderma lucidum polysaccharides. Natl Med J China 2003;83:1999-2000.
29. Ceriello A: Oxidative stress and diabetesassociated complications. Endocr Pract 2006;12:60-62.
30. Channon KM: Tetrahydrobiopterin: Regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 2004;14:323-327. (Pubitemid 41110612)
31. Zhang GL, Wang YH, Ni W, Teng HL, Lin ZB: Hepatoprotective role of ganoderma lucidum polysaccharide against bcg-induced immune liver injury in mice. World J Gastroenterol 2002;8:728-733. (Pubitemid 34918672)
32. Woo CW, Man RY, Siow YL, Choy PC, Wan EW, Lau CS, O K: Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages. Mol Cell Biochem 2005;275:165-171. (Pubitemid 41038405)
33. Huisman A, Vos I, van Faassen EE, Joles JA, Grone HJ, Martasek P, van Zonneveld AJ, Vanin AF, Rabelink TJ: Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: Modulation of inducible nitric oxide synthase. Faseb J 2002;16:1135-1137.
34. Shen GX: Oxidative stress and diabetic cardiovascular disorders: Roles of mitochondria and nadph oxidase. Can J Physiol Pharmacol 2010;88:241-248.
35. Camici GG, Schiavoni M, Francia P, Bachschmid M, Martin-Padura I, Hersberger M, Tanner FC, Pelicci P, Volpe M, Anversa P, Luscher TF, Cosentino F: Genetic deletion of p66(shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007;104:5217-5222. (Pubitemid 47186202)
36. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieckowski MR, Del Sal G, Pelicci PG, Rizzuto R: Protein kinase c beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66shc. Science 2007;315:659-663. (Pubitemid 46214712)
37. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino F: Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004;110:2889-2895. (Pubitemid 39473614)
38. Tho LL, Candlish JK, Thai AC: Correlates of diabetes markers with erythrocytic enzymes decomposing reactive oxygen species. Ann Clin Biochem 1988;25:426-431.
39. Jia J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC, Dong XC: Evaluation of in vivo antioxidant activities of ganoderma lucidum polysaccharides in stz-diabetic rats. Food Chem 2009;115:32-36.
40. Chen LH, Lin ZB, Li WD: Ganoderma lucidum polysaccharides reduce methotrexate-induced small intestinal damage in mice via induction of epithelial cell proliferation and migration. Acta Pharmacol Sin 2011;32:1505-1512.
41. Haendeler J, Dimmeler S: Inseparably tied: Functional and antioxidative capacity of endothelial progenitor cells. Circ Res 2006;98:157-158.
42. Wang XR, Zhang MW, Chen DD, Zhang Y, Chen AF: Amp-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes. Am J Physiol Endocrinol Metab 2011;300:E1135-1145.
43. Redondo-Horcajo M, Romero N, Martinez-Acedo P, Martinez-Ruiz A, Quijano C, Lourenco CF, Movilla N, Enriquez JA, Rodriguez-Pascual F, Rial E, Radi R, Vazquez J, Lamas S: Cyclosporine a-induced nitration of tyrosine 34 mnsod in endothelial cells: Role of mitochondrial superoxide. Cardiovasc Res 2010;87:356-365.
44. Moreno DM, Marti MA, De Biase PM, Estrin DA, Demicheli V, Radi R, Boechi L: Exploring the molecular basis of human manganese superoxide dismutase inactivation mediated by tyrosine 34 nitration. Arch Biochem Biophys 2011;507:304-309.